Replies to post #106671 on Biotech Values

[iwfal]

But, don't you think that it is very likely that, at a minimum, HCV DAA combos will be used in the not-too-distant future to treat HCV?

Of course - I am 'only' arguing against the position that it is a virtual certainty that DAA's will eliminate the need to have SOC as part of the combo.

PS Amusing that my clarification/restatement of my position should cause confusion. Especially since we have had this dialog before.